Companies / Latvia
Olainfarm To Export TB Drug To Kazakhstan
February 2007 | FDI AlertLatvian firm Olainfarm has been awarded a contract by the government of Kazakhstan to supply LVL974,000 (US$1.8mn) of PASA - sodium salt (aminosalicylic acid), a treatment for tuberculosis (TB). BMI is impressed at this deal as it demonstrates Olainfarm expansionist policy into a country that presents clear opportunities for foreign drugmakers, despite the less than ideal operating conditions. Furthermore, the contract is the largest ever signed by the company and will ensure ongoing financial strength, enabling investment in other, more lucrative TB markets, such as
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
